48 results on '"Duan, Zhong-Ping"'
Search Results
2. Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
3. Additional file 1 of Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence
4. Additional file 2 of Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence
5. Additional file 3 of Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence
6. Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence.
7. An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus
8. Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
9. Lipidomic profiling of plasma in patients with chronic hepatitis C infection
10. Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study
11. Chinese guidelines on the management of liver cirrhosis (abbreviated version)
12. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial
13. Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial
14. Platelet count is closely associated with the severity of liver injury in patients with chronic hepatitis B virus infection: A cross‑sectional study
15. Chinese guidelines on management of hepatic encephalopathy in cirrhosis
16. The Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Patients with HBV-Related Liver Disease
17. Idiopathic portal hypertension presenting with hepatic nodular regenerative hyperplasia after splenectomy: a case report
18. Retraction Note: Construction of Gpm6a/ReelinGFPCreERT2 by BAC recombination using a specific gene in hepatic mesothelial or stellate cells
19. A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?
20. Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB
21. Current treatment status and barriers for patients with chronic HCV infection in mainland China
22. Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure
23. Construction of Gpm6a/ReelinGFPCreERT2 by BAC recombination using a specific gene in hepatic mesothelial or stellate cells
24. M2-like Kupffer cells in fibrotic liver may protect against acute insult
25. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
26. Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
27. Up-regulation of Plasma Hexosylceramide (d18
28. Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces
29. Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection
30. Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China
31. Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study
32. Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure
33. Plasma Sphingolipids as Potential Indicators of Hepatic Necroinflammation in Patients with Chronic Hepatitis C and Normal Alanine Aminotransferase Level
34. Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma
35. Inhibition of 5-Lipoxygenase Pathway Attenuates Acute Liver Failure by Inhibiting Macrophage Activation
36. Lipidomic profiling of plasma in patients with chronic hepatitis C infection
37. T Lymphocytes from Chronic HCV-Infected Patients Are Primed for Activation-Induced Apoptosis and Express Unique Pro-Apoptotic Gene Signature
38. Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study.
39. Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB
40. Resting energy expenditure and glucose, protein and fat oxidation in severe chronic virus hepatitis B patients
41. Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model
42. Construction of Gpm6a/Reelin GFPCreERT2 by BAC recombination using a specific gene in hepatic mesothelial or stellate cells.
43. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
44. Impact of partial reimbursement on hepatitis B antiviral utilization and adherence.
45. Clinical relevance of hepatitis B virus variants.
46. Autophagy in anti-apoptotic effect of augmenter of liver regeneration in HepG2 cells.
47. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
48. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.